Design and x-ray crystal structures of high-potency nonsteroidal glucocorticoid agonists exploiting a novel binding site on the receptor
Authors:
- 27 October 2009
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 106 (43) , 18114-18119
Abstract
Crystallography and computer modeling have been used to exploit a previously unexplored channel in the glucocorticoid receptor (GR). Highly potent, nonsteroidal indazole amides showing excellent complementarity to the channel were designed with the assistance of the computational technique AlleGrow. The accuracy of the design process was demonstrated through crystallographic structural determination of the GR ligand-binding domain–agonist complex of the D-prolinamide derivative 11 . The utility of the channel was further exemplified through the design of a potent phenylindazole in which structural motifs, seen to interact with the traditional GR ligand pocket, were abandoned and replaced by interactions within the new channel. Occupation of the channel was confirmed with a second GR crystal structure of this truncated D-alaninamide derivative 13 . Compound 11 displays properties compatible with development as an intranasal solution formulation, whereas oral bioavailability has been demonstrated with a related truncated exemplar 14 . Data with the pyrrolidinone amide 12 demonstrate the potential for further elaboration within the “meta” channel to deliver compounds with selectivity for the desired transrepressive activity of glucocorticoids. The discovery of these interactions with this important receptor offers significant opportunities for the design of novel GR modulators.Keywords
This publication has 24 references indexed in Scilit:
- Aryl aminopyrazole benzamides as oral non-steroidal selective glucocorticoid receptor agonistsBioorganic & Medicinal Chemistry Letters, 2009
- The first X-ray crystal structure of the glucocorticoid receptor bound to a non-steroidal agonistBioorganic & Medicinal Chemistry Letters, 2008
- Dissociated non-steroidal glucocorticoid receptor modulators: an update on new compoundsExpert Opinion on Therapeutic Patents, 2008
- Doubling the Size of the Glucocorticoid Receptor Ligand Binding Pocket by DeacylcortivazolMolecular and Cellular Biology, 2008
- Antiinflammatory glucocorticoid receptor ligand with reduced side effects exhibits an altered protein–protein interaction profileProceedings of the National Academy of Sciences, 2007
- Non-steroidal glucocorticoid agonists—The discovery of aryl pyrazoles as A-ring mimeticsBioorganic & Medicinal Chemistry Letters, 2007
- Pharmacological properties of the enhanced-affinity glucocorticoid fluticasone furoate in vitro and in an in vivo model of respiratory inflammatory diseaseAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2007
- Dissociated non-steroidal glucocorticoids: tuning out untoward effectsExpert Opinion on Therapeutic Patents, 2007
- Fluticasone FuroateDrugs of the Future, 2007
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsAdvanced Drug Delivery Reviews, 1997